Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy

We herein report a 63-year-old woman with small-cell lung cancer (SCLC) who developed dermatomyositis (DM) after initial chemoradiotherapy despite tumor reduction. Serum anti-transcriptional in termediary factor (TIF) 1γ antibody was detected before the development of DM, and its levels increased ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Aritomi, Takafumi, Kido, Takashi, Nakano, Kazuhisa, Satoh, Yurie, Noguchi, Shingo, Jotatsu, Takanobu, Hanaka, Tetsuya, Satoh, Minoru, Tanaka, Yoshiya, Yatera, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395139/
https://www.ncbi.nlm.nih.gov/pubmed/30210109
http://dx.doi.org/10.2169/internalmedicine.1007-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395139/
https://www.ncbi.nlm.nih.gov/pubmed/30210109
http://dx.doi.org/10.2169/internalmedicine.1007-18

Ejemplares similares